Iguratimod
A novel disease-modifying antirheumatic drug that inhibits NF-kappaB (NF-κB) p65 subunit (RelA) phosphorylation and nuclear translocation without affecting IKBα degradation.
Product Specifications
CAS Number
123663-49-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
374.3679
Molecular Formula
C17H14N2O6S
Notes
Research use only, not for human use.
Receptor
COX-2|MIF
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
